{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:28:01Z","timestamp":1794569281111,"version":"4.9.1"},"reference-count":314,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neuron.2025.08.015","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:13:22Z","timestamp":1756912402000},"page":"2791-2813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Novel approaches to clinical trial design in cancer neuroscience"],"prefix":"10.1016","volume":"113","author":[{"given":"Gregory","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong T.T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico O.","family":"Gleber-Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay K.","family":"Puduvalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Monje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2025.08.015_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147276","article-title":"Tumor innervation: peripheral nerves take control of the tumor microenvironment","volume":"131","author":"Gysler","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuron.2025.08.015_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41388-019-1006-0","article-title":"Neurotransmitters: emerging targets in cancer","volume":"39","author":"Jiang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.neuron.2025.08.015_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","article-title":"The neuroscience of cancer","volume":"618","author":"Mancusi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s40001-023-01275-4","article-title":"Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects","volume":"28","author":"Mohi-ud-din","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib6","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.7150\/thno.69682","article-title":"Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy","volume":"12","author":"Upton","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.neuron.2025.08.015_bib7","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","article-title":"Glioblastoma hijacks neuronal mechanisms for brain invasion","volume":"185","author":"Venkataramani","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: State of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1158\/2159-8290.CD-23-1495","article-title":"Next Directions in the Neuroscience of Cancers Arising outside the CNS","volume":"14","author":"Amit","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib10","doi-asserted-by":"crossref","first-page":"e2200122","DOI":"10.1002\/adbi.202200122","article-title":"Neuron\u2013Glial Interactions in Health and Brain Cancer","volume":"6","author":"Pan","year":"2022","journal-title":"Adv. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41568-025-00831-w","article-title":"Neuro-immune cross-talk in cancer","volume":"25","author":"Amit","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1158\/1541-7786.MCR-25-0124","article-title":"The Bridging Role of Schwann Cells in the Interaction between Tumors and the Nervous System: A Potential Target for Cancer Therapy","volume":"23","author":"Zhang","year":"2025","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","volume":"639","author":"Barron","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.608911","article-title":"Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","article-title":"NF1 mutation drives neuronal activity-dependent initiation of optic glioma","volume":"594","author":"Pan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41586-022-04719-9","article-title":"Olfactory sensory experience regulates gliomagenesis via neuronal IGF1","volume":"606","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41586-023-06036-1","article-title":"Glioblastoma remodelling of human neural circuits decreases survival","volume":"617","author":"Krishna","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib23","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","article-title":"\u03b22 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer","volume":"33","author":"Renz","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1349-7006.2002.tb01313.x","article-title":"Psychosocial stress augments tumor development through beta-adrenergic activation in mice","volume":"93","author":"Hasegawa","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance","volume":"611","author":"Balood","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200019","article-title":"Sensory Neurotransmitter Calcitonin Gene-Related Peptide Modulates Tumor Growth and Lymphocyte Infiltration in Oral Squamous Cell Carcinoma","volume":"6","author":"McIlvried","year":"2022","journal-title":"Adv. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neuron.2025.08.015_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","article-title":"Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling","volume":"31","author":"Hayakawa","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib31","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","article-title":"Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness","volume":"8","author":"Renz","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib32","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1158\/0008-5472.CAN-16-1701","article-title":"Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction","volume":"78","author":"Allen","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200089","article-title":"The Role of Schwann Cells in Cancer","volume":"6","author":"Deborde","year":"2022","journal-title":"Adv. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib34","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1038\/s41467-023-40314-w","article-title":"Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment","volume":"14","author":"Xue","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib35","article-title":"Mechanical cues of extracellular matrix determine tumor innervation","author":"Jiang","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuron.2025.08.015_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-022-05520-4","article-title":"Autonomous rhythmic activity in glioma networks drives brain tumour growth","volume":"613","author":"Hausmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib37","doi-asserted-by":"crossref","first-page":"C255","DOI":"10.1152\/ajpcell.00047.2011","article-title":"Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer","volume":"301","author":"Becchetti","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cancers7020813","article-title":"Voltage-gated ion channels in cancer cell proliferation","volume":"7","author":"Rao","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neuron.2025.08.015_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71670-y","article-title":"Chronic neural activity recorded within breast tumors","volume":"10","author":"McCallum","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-019-0046-z","article-title":"Synthetic lethality as an engine for cancer drug target discovery","volume":"19","author":"Huang","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.neuron.2025.08.015_bib42","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","article-title":"A phase I\/II study of triple-mutated oncolytic herpes virus G47\u0394 in patients with progressive glioblastoma","volume":"13","author":"Todo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41591-019-0723-9","article-title":"Visualization of AMPA receptors in living human brain with positron emission tomography","volume":"26","author":"Miyazaki","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nucmedbio.2022.04.009","article-title":"Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors","volume":"110-111","author":"Arisawa","year":"2022","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41408-024-01118-3","article-title":"Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms","volume":"14","author":"Banks","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.neuron.2025.08.015_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/pbc.22238","article-title":"Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis","volume":"53","author":"Gavhed","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib47","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bjh.18247","article-title":"Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma","volume":"198","author":"Sveijer","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.neuron.2025.08.015_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102852","article-title":"Neurofilament Light Chain as A Biomarker for Brain Metastases","volume":"12","author":"Winther-Larsen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neuron.2025.08.015_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2022.864910","article-title":"Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions","volume":"3","author":"Rodwin","year":"2022","journal-title":"Front. Pain Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154395","article-title":"Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy","volume":"7","author":"Huehnchen","year":"2022","journal-title":"JCI insight"},{"key":"10.1016\/j.neuron.2025.08.015_bib51","doi-asserted-by":"crossref","first-page":"942960","DOI":"10.3389\/fonc.2022.942960","article-title":"Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers","volume":"12","author":"Kim","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib52","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/neuonc\/noac004","article-title":"Liquid biopsy in gliomas: A RANO review and proposals for clinical applications","volume":"24","author":"Soffietti","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib53","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41591-024-02969-w","article-title":"A prognostic neural epigenetic signature in high-grade glioma","volume":"30","author":"Drexler","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib54","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1038\/s41467-025-59614-4","article-title":"Gabapentinoids confer survival benefit in human glioblastoma","volume":"16","author":"Bernstock","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib55","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/neuonc\/nox029","article-title":"The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria","volume":"19","author":"Nayak","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/neuonc\/now190","article-title":"Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials","volume":"19","author":"Avila","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib57","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer","volume":"18","author":"Cole","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123741","article-title":"Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance","volume":"12","author":"Hunt","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neuron.2025.08.015_bib60","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/s41467-018-06640-0","article-title":"Cancer exosomes induce tumor innervation","volume":"9","author":"Madeo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ygyno.2019.04.651","article-title":"Innervation of cervical carcinoma is mediated by cancer-derived exosomes","volume":"154","author":"Lucido","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215260","article-title":"Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy","volume":"13","author":"Jung","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neuron.2025.08.015_bib63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-24-0287","article-title":"Neuro-Mesenchymal Interaction Mediated by a \u03b22-Adrenergic Nerve Growth Factor Feedforward Loop Promotes Colorectal Cancer Progression","volume":"15","author":"Kobayashi","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41419-023-05965-z","article-title":"Cancer associated fibroblast derived SLIT2 drives gastric cancer cell metastasis by activating NEK9","volume":"14","author":"Lu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuron.2025.08.015_bib65","doi-asserted-by":"crossref","first-page":"eadi0178","DOI":"10.1126\/scitranslmed.adi0178","article-title":"Extracellular vesicle\u2013packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models","volume":"16","author":"Zheng","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib66","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/neuonc\/noz175.574","article-title":"Barriers to accrual and enrollment in brain tumor trials","volume":"21","author":"Lee","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib67","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1200\/JCO.2009.22.4949","article-title":"Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer","volume":"27","author":"Liebig","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/PAS.0000000000000422","article-title":"Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma","volume":"39","author":"Holthoff","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.neuron.2025.08.015_bib69","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12105-021-01321-9","article-title":"Interobserver Variation in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma: Phase 2 Survey Study","volume":"15","author":"Yan","year":"2021","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.neuron.2025.08.015_bib70","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049729","article-title":"Understanding and modeling nerve-cancer interactions","volume":"16","author":"Le","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuron.2025.08.015_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102361","article-title":"Improving precision surgery: A review of current intraoperative nerve tissue fluorescence imaging","volume":"76","author":"Wang","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121563","article-title":"Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review","volume":"17","author":"Chang","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuron.2025.08.015_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109111","article-title":"Modeling the precise interaction of glioblastoma with human brain region-specific organoids","volume":"27","author":"Fan","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.neuron.2025.08.015_bib74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2024.11.010","article-title":"Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy","volume":"32","author":"Logun","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib75","doi-asserted-by":"crossref","first-page":"16399","DOI":"10.1038\/s41598-022-20487-y","article-title":"Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib77","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400725RR","article-title":"The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders","volume":"38","author":"Cavalu","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.neuron.2025.08.015_bib78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41420-022-00930-9","article-title":"Targeting tumor innervation: premises, promises, and challenges","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib80","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib81","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","article-title":"\u03b2-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy","volume":"77","author":"Bucsek","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10634","article-title":"Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination","volume":"7","author":"Le","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib83","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.1512603113","article-title":"Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer","volume":"113","author":"Saloman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.08.015_bib84","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.stem.2015.02.006","article-title":"Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches","volume":"16","author":"Peterson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pros.1137","article-title":"In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer","volume":"49","author":"Ayala","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.neuron.2025.08.015_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108177","article-title":"Anti-cancer activity of sustained release capsaicin formulations","volume":"238","author":"Merritt","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib87","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-022-00475-0","article-title":"Disconnecting multicellular networks in brain tumours","volume":"22","author":"Venkataramani","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib88","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2008.21.6895","article-title":"Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial","volume":"27","author":"Grossman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12885-024-11846-1","article-title":"PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma","volume":"24","author":"Heuer","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12100","article-title":"Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist","volume":"127","author":"Rogawski","year":"2013","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neuron.2025.08.015_bib91","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.21873\/anticanres.12737","article-title":"Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel - PubMed","volume":"38","author":"Izumoto","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib92","doi-asserted-by":"crossref","first-page":"e01612","DOI":"10.1002\/brb3.1612","article-title":"Perampanel in brain tumor-related epilepsy: Observational pilot study","volume":"10","author":"Maschio","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuron.2025.08.015_bib93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2176\/nmc.oa.2018-0245","article-title":"Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy","volume":"60","author":"Chonan","year":"2020","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.neuron.2025.08.015_bib94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fneur.2020.00592","article-title":"Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)","volume":"11","author":"Coppola","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuron.2025.08.015_bib95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","article-title":"The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist","volume":"56","author":"Patsalos","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2025.08.015_bib96","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpba.2017.11.008","article-title":"Pharmacokinetics and brain uptake study of novel AMPA receptor antagonist perampanel in SD rats using a validated UHPLC-QTOF-MS method","volume":"149","author":"Paul","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.neuron.2025.08.015_bib97","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41467-025-60074-z","article-title":"Glioma-neuronal circuit remodeling induces regional immunosuppression","volume":"16","author":"Nejo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib98","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3171\/2021.1.JNS202482","article-title":"Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma","volume":"136","author":"Medikonda","year":"2021","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuron.2025.08.015_bib99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302126120","article-title":"NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages","volume":"120","author":"Yuan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.08.015_bib100","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1177\/15353702211032549","article-title":"Therapeutically leveraging GABAA receptors in cancer","volume":"246","author":"Bhattacharya","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib101","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/onc.2016.245","article-title":"Endogenous GABAA receptor activity suppresses glioma growth","volume":"36","author":"Blanchart","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.neuron.2025.08.015_bib102","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00401-013-1205-7","article-title":"\u03b15-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth","volume":"127","author":"Sengupta","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2025.08.015_bib103","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2020.10.025","article-title":"Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity","volume":"109","author":"Krummel","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.neuron.2025.08.015_bib104","article-title":"GABA\/baclofen stabilizes PD-L1 and enhances immunotherapy of breast cancer","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neuron.2025.08.015_bib105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","article-title":"Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression","volume":"24","author":"Huang","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib106","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41401-022-01023-0","article-title":"Antitumor pharmacological research in the era of personalized medicine","volume":"43","author":"Huang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuron.2025.08.015_bib107","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","article-title":"B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity","volume":"599","author":"Zhang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib108","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.30443","article-title":"Use of benzodiazepine and risk of cancer: A meta-analysis of observational studies","volume":"140","author":"Kim","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib109","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.40.10.1014","article-title":"A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180","volume":"40","author":"Cohen","year":"1954","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.08.015_bib110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","article-title":"Targeting TRK family proteins in cancer","volume":"173","author":"Khotskaya","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040105","article-title":"Inhibiting TRK Proteins in Clinical Cancer Therapy","volume":"10","author":"Lange","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neuron.2025.08.015_bib112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-019-1385-8","article-title":"Neurotrophins and their involvement in digestive cancers","volume":"10","author":"Blondy","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuron.2025.08.015_bib113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cjp2.307","article-title":"Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours","volume":"9","author":"Li","year":"2023","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib114","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.2147\/DDDT.S147384","article-title":"Entrectinib and other ALK\/TRK inhibitors for the treatment of neuroblastoma","volume":"12","author":"Pacenta","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib115","doi-asserted-by":"crossref","first-page":"e1268","DOI":"10.1093\/oncolo\/oyad188","article-title":"A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis","volume":"28","author":"Fallon","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.neuron.2025.08.015_bib116","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/s41467-024-47633-6","article-title":"Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib117","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bcp.12850","article-title":"Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain","volume":"81","author":"Jonsson","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib118","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1298473","article-title":"Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications","volume":"2016","author":"Kuriakose","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib119","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","article-title":"Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives","volume":"36","author":"Dumont","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.neuron.2025.08.015_bib120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib121","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1093\/neuonc\/noae064.035","article-title":"CNSC-02. PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-056: A PHASE 1 STUDY OF THE ADAM-10 INHIBITOR, INCB007839, IN CHILDREN WITH RECURRENT\/PROGRESSIVE HIGH-GRADE GLIOMAS TO TARGET MICROENVIRONMENTAL NEUROLOGIN-3","volume":"26","author":"Lenzen","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib122","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1158\/0008-5472.SABCS-09-5056","article-title":"Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients","volume":"69","author":"Friedman","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib123","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1172\/JCI120616","article-title":"Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington\u2019s disease","volume":"129","author":"Vezzoli","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuron.2025.08.015_bib124","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1523\/JNEUROSCI.5910-12.2013","article-title":"Postnatal disruption of the disintegrin\/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions","volume":"33","author":"Prox","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib125","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/ijms19082281","article-title":"Association between Obesity and Circulating Brain-Derived Neurotrophic Factor (BDNF) Levels: Systematic Review of Literature and Meta-Analysis","volume":"19","author":"Sandrini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib126","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1038\/s41598-023-33842-4","article-title":"Obesity-related parameters in carriers of some BDNF genetic variants may depend on daily dietary macronutrients intake","volume":"13","author":"Miksza","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib127","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nn1336","article-title":"A de novo mutation affecting human TrkB associated with severe obesity and developmental delay","volume":"7","author":"Yeo","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib128","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nn1073","article-title":"Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor","volume":"6","author":"Xu","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7570\/jomes20107","article-title":"Association of Circulating Brain-Derived Neurotrophic Factor with Cognition among Adult Obese Population","volume":"30","author":"Katuri","year":"2021","journal-title":"J. Obes. Metab. Syndr."},{"key":"10.1016\/j.neuron.2025.08.015_bib130","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.2337\/db06-0550","article-title":"Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene","volume":"55","author":"Gray","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.neuron.2025.08.015_bib131","article-title":"Relationship between serum brain-derived neurotrophic factor and cognitive impairment in children with sleep-disordered breathing","volume":"10","author":"Feng","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.neuron.2025.08.015_bib132","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib133","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neuron.2025.08.015_bib134","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/chi.2016.0255","article-title":"Obese Adolescents Show Reduced Cognitive Processing Speed Compared with Healthy Weight Peers","volume":"13","author":"Sweat","year":"2017","journal-title":"Child. Obes."},{"key":"10.1016\/j.neuron.2025.08.015_bib135","article-title":"Childhood obesity\u2019s effect on cognition and brain connectivity worsens with low family income","volume":"9","author":"Tomasi","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuron.2025.08.015_bib136","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1542\/peds.2012-0324","article-title":"Obesity and metabolic syndrome and functional and structural brain impairments in adolescence","volume":"130","author":"Yau","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuron.2025.08.015_bib137","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/oby.20801","article-title":"Preliminary evidence of cognitive and brain abnormalities in uncomplicated adolescent obesity","volume":"22","author":"Yau","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.neuron.2025.08.015_bib138","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/cercor\/bhz257","article-title":"Childhood Obesity, Cortical Structure, and Executive Function in Healthy Children","volume":"30","author":"Ronan","year":"2020","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuron.2025.08.015_bib139","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2352-4642(19)30404-3","article-title":"Adolescent obesity and dietary decision making-a brain-health perspective","volume":"4","author":"Lowe","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.neuron.2025.08.015_bib140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11916-019-0774-0","article-title":"Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review","volume":"23","author":"Viswanath","year":"2019","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib141","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41416-024-02622-w","article-title":"Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels","volume":"130","author":"Djamgoz","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib142","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jid.2022.08.038","article-title":"The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma","volume":"143","author":"Lasheras-Otero","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neuron.2025.08.015_bib143","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.3390\/ijms21249660","article-title":"Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity","volume":"21","author":"Guth","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib144","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41391-019-0128-3","article-title":"Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate","volume":"22","author":"Bugan","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.neuron.2025.08.015_bib145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2012.03.036","article-title":"Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo","volume":"323","author":"Yildirim","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuron.2025.08.015_bib146","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1476-4598-13-264","article-title":"Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization","volume":"13","author":"Driffort","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib147","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ejhf.50","article-title":"Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction","volume":"16","author":"Tocchetti","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.neuron.2025.08.015_bib148","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fphys.2018.00038","article-title":"Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production","volume":"9","author":"Riccio","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib149","article-title":"Ranolazine Effectively Ameliorated Brain Pathologies and Cognitive Decline in Rats with Trastuzumap-Induced Chemobrain","volume":"18","author":"Chunchai","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuron.2025.08.015_bib150","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/19336950.2017.1380758","article-title":"Distribution and function of voltage-gated sodium channels in the nervous system","volume":"11","author":"Wang","year":"2017","journal-title":"Channels"},{"key":"10.1016\/j.neuron.2025.08.015_bib151","first-page":"1","article-title":"Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges","volume":"183","author":"Capatina","year":"2022","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib152","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1200\/JCO.22.01966","article-title":"Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer","volume":"41","author":"Badwe","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib153","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s42255-023-00861-4","article-title":"Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy","volume":"5","author":"Redondo-Mu\u00f1oz","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.neuron.2025.08.015_bib154","doi-asserted-by":"crossref","first-page":"23066","DOI":"10.1002\/jcp.28868","article-title":"Propranolol inhibits neonatal Nav1.5 activity and invasiveness of MDA-MB-231 breast cancer cells: Effects of combination with ranolazine","volume":"234","author":"Lee","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2010.00144","article-title":"Propranolol Blocks Cardiac and Neuronal Voltage-Gated Sodium Channels","volume":"1","author":"Wang","year":"2010","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib156","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10585-022-10166-7","article-title":"Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine - PubMed","volume":"39","author":"Qiu","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.neuron.2025.08.015_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120584","article-title":"Epilepsy and brain tumors: Two sides of the same coin","volume":"446","author":"Aronica","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib158","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/molpharm.121.000336","article-title":"Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor","volume":"100","author":"Free","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib159","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1523\/JNEUROSCI.1589-18.2018","article-title":"Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma","volume":"39","author":"Caragher","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib160","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/neuonc\/noae031","article-title":"ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma","volume":"26","author":"Arrillaga-Romany","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.990665","article-title":"Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib162","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/15548627.2019.1669869","article-title":"The secret life of degradative lysosomes in axons: delivery from the soma, enzymatic activity, and local autophagic clearance","volume":"16","author":"Farfel-Becker","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.neuron.2025.08.015_bib163","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.celrep.2019.06.013","article-title":"Neuronal Soma-Derived Degradative Lysosomes Are Continuously Delivered to Distal Axons to Maintain Local Degradation Capacity","volume":"28","author":"Farfel-Becker","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib164","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.7150\/thno.42440","article-title":"Tumor-neuroglia interaction promotes pancreatic cancer metastasis","volume":"10","author":"Su","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.neuron.2025.08.015_bib165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13046-021-02198-w","article-title":"Autophagic Schwann cells promote perineural invasion mediated by the NGF\/ATG7 paracrine pathway in pancreatic cancer","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib166","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1002\/cam4.4211","article-title":"Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma","volume":"10","author":"AlMasri","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib167","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clbc.2020.09.015","article-title":"A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer","volume":"21","author":"Anand","year":"2021","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib168","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1245\/s10434-015-4566-4","article-title":"Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma","volume":"22","author":"Boone","year":"2015","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib169","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/1078-0432.CCR-19-4042","article-title":"A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine\/Nab-Paclitaxel in Pancreatic Cancer Patients","volume":"26","author":"Zeh","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib170","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3171\/foc.2003.14.2.4","article-title":"Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine","volume":"14","author":"Brice\u00f1o","year":"2003","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.neuron.2025.08.015_bib171","doi-asserted-by":"crossref","first-page":"v154","DOI":"10.1093\/annonc\/mdz243.035","article-title":"CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma","volume":"30","author":"Compter","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib172","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1523\/JNEUROSCI.0951-20.2020","article-title":"Deletion of Calcineurin in Schwann Cells Does Not Affect Developmental Myelination, But Reduces Autophagy and Delays Myelin Clearance after Peripheral Nerve Injury","volume":"40","author":"Reed","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib173","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","article-title":"Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study","volume":"359","author":"Yang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.neuron.2025.08.015_bib174","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/s41388-021-01763-z","article-title":"Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells","volume":"40","author":"Lao","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.neuron.2025.08.015_bib175","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-022-00492-7","article-title":"RCAN1-mediated calcineurin inhibition as a target for cancer therapy","volume":"28","author":"Lao","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib176","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41467-020-15770-3","article-title":"Midkine activation of CD8+ T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth","volume":"11","author":"Guo","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.08.015_bib177","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neo.2015.10.002","article-title":"RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth","volume":"17","author":"Solga","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.neuron.2025.08.015_bib178","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1524-4741.2012.01246.x","article-title":"Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer","volume":"18","author":"Morris","year":"2012","journal-title":"Breast J."},{"key":"10.1016\/j.neuron.2025.08.015_bib179","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1038\/s41388-019-0756-z","article-title":"Estradiol induces BDNF\/TrkB signaling in triple-negative breast cancer to promote brain metastases","volume":"38","author":"Contreras-Z\u00e1rate","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.neuron.2025.08.015_bib180","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1097\/NCC.0000000000001152","article-title":"Effectiveness of Nonpharmacologic Interventions for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review and Network Meta-analysis","volume":"46","author":"Liu","year":"2023","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.neuron.2025.08.015_bib181","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3857\/roj.2024.00269","article-title":"Role of memantine to mitigate radiation-induced cognitive dysfunction in brain metastasis patient receiving whole brain radiotherapy: a systematic review","volume":"42","author":"Oktavianda","year":"2024","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/j.neuron.2025.08.015_bib182","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S1470-2045(18)30938-0","article-title":"Pharmacologic management of cognitive impairment induced by cancer therapy","volume":"20","author":"Karschnia","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib183","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10238-025-01708-w","article-title":"Donepezil for cancer-related cognitive impairment: systematic review and meta-analysis","volume":"25","author":"Fornalik","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib184","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.12004","article-title":"Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest NCORP Research Base REMEMBER trial (WF97116)","volume":"41","author":"Rapp","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib185","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11764-019-00786-6","article-title":"Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study","volume":"13","author":"Vega","year":"2019","journal-title":"J. Cancer Surviv."},{"key":"10.1016\/j.neuron.2025.08.015_bib186","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5707","article-title":"The effects of docosahexaenoic acid supplementation on cognition and well-being in mild cognitive impairment: A 12-month randomised controlled trial","volume":"37","author":"Mengelberg","year":"2022","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib187","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1748-717X-5-6","article-title":"Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus","volume":"5","author":"Jenrow","year":"2010","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib188","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.12116","article-title":"Nationwide phase II randomized controlled trial of low-dose ibuprofen vs placebo for cancer-related cognitive impairment (CRCI)","volume":"41","author":"Janelsins","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib189","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00432-018-2791-5","article-title":"Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial","volume":"145","author":"Cramer","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib190","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/app15041925","article-title":"Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment","volume":"15","author":"Vasileiou","year":"2025","journal-title":"Appl. Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2106","article-title":"Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells","volume":"11","author":"Esmaeili","year":"2023","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib192","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JGO.2019.5.suppl.83","article-title":"Randomized phase II clinical trial of pioglitazone plus chemotherapy versus chemotherapy alone in patients with metastatic breast cancer","volume":"5","author":"Moghareabed","year":"2019","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib193","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/cncr.30490","article-title":"Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study","volume":"123","author":"Rousselot","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib194","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","article-title":"Neuronal substance P drives metastasis through an extracellular RNA\u2013TLR7 axis","volume":"633","author":"Padmanaban","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib195","article-title":"Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues","volume":"16","author":"Wen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuron.2025.08.015_bib196","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10787-016-0271-6","article-title":"Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms","volume":"24","author":"Kaur","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuron.2025.08.015_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123210","article-title":"Repurposing Aprepitant: Can it protect against doxorubicin-induced Chemobrain beyond its antiemetic role?","volume":"359","author":"Gomaa","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib198","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/cancers17030520","article-title":"Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma","volume":"17","author":"Mu\u00f1oz","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.neuron.2025.08.015_bib199","first-page":"50","article-title":"Neurokinin-1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report","volume":"11","author":"Mu\u00f1oz","year":"2019","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123289","article-title":"Memantine Monotherapy for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"10","author":"Matsunaga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuron.2025.08.015_bib201","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.2003.029074","article-title":"Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease","volume":"75","author":"Rockwood","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib202","doi-asserted-by":"crossref","first-page":"100195","DOI":"10.1016\/j.tjpad.2025.100195","article-title":"The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis","author":"Hsu","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neuron.2025.08.015_bib203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2377-7-26","article-title":"The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial","volume":"7","author":"Rockwood","year":"2007","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuron.2025.08.015_bib204","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-023-01356-w","article-title":"NeuroEPO plus (NeuralCIM\u00ae) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial","volume":"15","author":"Sosa","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40263-018-0598-1","article-title":"Alzheimer\u2019s Disease Clinical Trials: Moving Toward Successful Prevention","volume":"33","author":"Rafii","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuron.2025.08.015_bib206","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/mds.29045","article-title":"Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study","volume":"37","author":"Rodriguez-Labrada","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuron.2025.08.015_bib207","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12883-017-0908-0","article-title":"Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study","volume":"17","author":"Santos-Morales","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuron.2025.08.015_bib208","doi-asserted-by":"crossref","DOI":"10.9758\/cpn.23.1081","article-title":"Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder","volume":"21","author":"McCarthy","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib209","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111572","article-title":"Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression","volume":"16","author":"Vecera","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuron.2025.08.015_bib210","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/HRP.0000000000000312","article-title":"Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review","volume":"29","author":"Souza-Marques","year":"2021","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.neuron.2025.08.015_bib211","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.21080800","article-title":"Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial","volume":"179","author":"Tabuteau","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib212","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40263-023-01032-5","article-title":"Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials","volume":"37","author":"Akbar","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuron.2025.08.015_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.642382","article-title":"Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis","volume":"11","author":"Ibrahim","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib214","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrneurol.2016.185","article-title":"Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours","volume":"13","author":"Makale","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuron.2025.08.015_bib215","doi-asserted-by":"crossref","first-page":"e31169","DOI":"10.1002\/pbc.31169","article-title":"Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function","volume":"71","author":"Harris","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib216","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1097\/MPH.0000000000001714","article-title":"Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series","volume":"43","author":"Fustino","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib217","doi-asserted-by":"crossref","first-page":"18548","DOI":"10.1038\/s41598-024-69263-0","article-title":"Potential neurotoxicity associated with methotrexate","volume":"14","author":"Apiraksattayakul","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib218","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pediatrneurol.2014.01.048","article-title":"Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity","volume":"50","author":"Afshar","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuron.2025.08.015_bib219","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/08880010290057336","article-title":"Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity","volume":"19","author":"Drachtman","year":"2002","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib220","first-page":"665","article-title":"Intrathecal methotrexate, central nervous system toxicity, and response to N-methyl-D-aspartate antagonism: An adult case series","volume":"11","author":"Donaghy","year":"2024","journal-title":"Neurooncol. Pract."},{"key":"10.1016\/j.neuron.2025.08.015_bib221","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41380-023-02397-1","article-title":"Targeting metaplasticity mechanisms to promote sustained antidepressant actions","volume":"29","author":"Brown","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib222","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109313","article-title":"Microglia enable mature perineuronal nets disassembly upon anesthetic ketamine exposure or 60-Hz light entrainment in the healthy brain","volume":"36","author":"Venturino","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib224","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1016\/j.cub.2020.07.008","article-title":"Subanesthetic Ketamine Reactivates Adult Cortical Plasticity to Restore Vision from Amblyopia","volume":"30","author":"Grieco","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib225","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial","volume":"179","author":"Price","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib226","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/JCP.0000000000001209","article-title":"Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder","volume":"40","author":"Freeman","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib227","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder","volume":"15","author":"Rong","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.neuron.2025.08.015_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.793677","article-title":"Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients","volume":"13","author":"Lan","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib229","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1049909111412539","article-title":"A Comparative Efficacy of Amitriptyline, Gabapentin, and Pregabalin in Neuropathic Cancer Pain: A Prospective Randomized Double-Blind Placebo-Controlled Study","volume":"29","author":"Mishra","year":"2012","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.neuron.2025.08.015_bib230","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/cncr.23482","article-title":"Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3","volume":"112","author":"Rao","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib231","first-page":"4223","article-title":"Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin","volume":"29","author":"Maih\u00f6fner","year":"2021","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib232","first-page":"833","article-title":"A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA","volume":"19","author":"Barton","year":"2011","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib233","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11864-021-00926-0","article-title":"Updates in the treatment of chemotherapy-induced peripheral neuropathy","volume":"23","author":"Mezzanotte","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib234","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib235","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib236","doi-asserted-by":"crossref","first-page":"e24134","DOI":"10.1200\/JCO.2023.41.16_suppl.e24134","article-title":"Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical trial (RCT)","volume":"41","author":"Gewandter","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib237","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/cncr.30649","article-title":"Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study","volume":"123","author":"Prinsloo","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib238","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cncr.35027","article-title":"Brain-computer interface relieves chronic chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial","volume":"130","author":"Prinsloo","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib239","article-title":"Combination of Transcranial Magnetic Stimulation and Ketamine in Treatment-Resistant Depression: A Systematic Review","volume":"16","author":"Arubuolawe","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.neuron.2025.08.015_bib240","first-page":"1157","article-title":"Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression","volume":"238","author":"Siegel","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuron.2025.08.015_bib241","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jagp.2022.11.013","article-title":"Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition","volume":"31","author":"Oughli","year":"2023","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuron.2025.08.015_bib242","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/EJA.0b013e32832d540e","article-title":"Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages","volume":"27","author":"Forget","year":"2010","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib243","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3892\/ijmm.2017.2875","article-title":"Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma\/astrocytoma cells","volume":"39","author":"Yamaguchi","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib244","doi-asserted-by":"crossref","first-page":"e820","DOI":"10.1136\/spcare-2022-003651","article-title":"Efficacy and safety of subcutaneous clonidine for refractory symptoms in palliative medicine: a retrospective study","volume":"13","author":"Howard","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.neuron.2025.08.015_bib245","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12902-023-01486-0","article-title":"Effectiveness of oral clonidine and gabapentin on peripheral neuropathy in diabetic patients in southwestern Iran: a randomized clinical trial","volume":"23","author":"Hassanzadeh","year":"2023","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.neuron.2025.08.015_bib246","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bja.2018.04.020","article-title":"Effect of clonidine on oncological outcomes after breast and lung cancer surgery","volume":"121","author":"Forget","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuron.2025.08.015_bib247","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/JPR.S504556","article-title":"The Addition of Intrathecal Clonidine to Reduce Medication-Related Side-Effects in Cancer Pain: A Retrospective Cohort Study","volume":"18","author":"Bulat","year":"2025","journal-title":"J. Pain Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib248","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.aat.2013.03.003","article-title":"Combination of oral clonidine and intravenous low-dose ketamine reduces the consumption of postoperative patient-controlled analgesia morphine after spine surgery","volume":"51","author":"Nitta","year":"2013","journal-title":"Acta Anaesthesiol. Taiwan"},{"key":"10.1016\/j.neuron.2025.08.015_bib249","doi-asserted-by":"crossref","DOI":"10.1242\/dev.201164","article-title":"The peripheral nervous system","volume":"150","author":"Murtazina","year":"2023","journal-title":"Development"},{"key":"10.1016\/j.neuron.2025.08.015_bib250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4330\/wjc.v7.i4.204","article-title":"Autonomic and endocrine control of cardiovascular function","volume":"7","author":"Gordan","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib251","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/j.2040-4603.2014.tb00587.x","article-title":"Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions","volume":"4","author":"Browning","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib252","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","article-title":"Cardiovascular protection using beta-blockers: a critical review of the evidence","volume":"50","author":"Bangalore","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib253","doi-asserted-by":"crossref","first-page":"II21","DOI":"10.1161\/01.HYP.11.3_Pt_2.II21","article-title":"Beta-adrenergic receptor blockers. Adverse effects and drug interactions","volume":"11","author":"Frishman","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.neuron.2025.08.015_bib254","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.annonc.2020.05.006","article-title":"Characterization of on-target adverse events caused by TRK inhibitor therapy","volume":"31","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10194-020-01097-3","article-title":"Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies","volume":"21","author":"Haanes","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuron.2025.08.015_bib256","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/60300142","article-title":"Muscarinic receptor agonists and antagonists","volume":"6","author":"Broadley","year":"2001","journal-title":"Molecules"},{"key":"10.1016\/j.neuron.2025.08.015_bib257","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009569","article-title":"Denervation suppresses gastric tumorigenesis","volume":"6","author":"Zhao","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib258","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pros.23454","article-title":"Influence of the neural microenvironment on prostate cancer","volume":"78","author":"Coarfa","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.neuron.2025.08.015_bib259","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16020096","article-title":"From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction","volume":"16","author":"Rempel","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.neuron.2025.08.015_bib260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11916-020-00878-4","article-title":"A Comprehensive Review of the Celiac Plexus Block for the Management of Chronic Abdominal Pain","volume":"24","author":"Urits","year":"2020","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib261","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf1147","article-title":"Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer","volume":"15","author":"Chang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib262","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.950167","article-title":"A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art","volume":"12","author":"Pinkiewicz","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib263","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2025.08.015_bib264","doi-asserted-by":"crossref","first-page":"e0148613","DOI":"10.1371\/journal.pone.0148613","article-title":"Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier","volume":"11","author":"Leuthardt","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuron.2025.08.015_bib265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11060-024-04786-0","article-title":"Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models","volume":"170","author":"Schlieper-Scherf","year":"2024","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib266","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib267","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00701-022-05192-z","article-title":"Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis","volume":"164","author":"Li","year":"2022","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.neuron.2025.08.015_bib268","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-023-04348-w","article-title":"Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis","volume":"164","author":"Ballo","year":"2023","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105068","article-title":"Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study","volume":"102","author":"Pruis","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuron.2025.08.015_bib270","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","article-title":"ANG1005, a Brain-Penetrating Peptide\u2013Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases","volume":"26","author":"Kumthekar","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib271","article-title":"CAR-T cell therapy for the treatment of adult high-grade gliomas","volume":"8","author":"Park","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib272","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib273","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41591-023-02276-w","article-title":"Tumor inflammation-associated neurotoxicity","volume":"29","author":"Mahdi","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib274","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuron.2025.08.015_bib275","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/neuonc\/noad087","article-title":"Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma","volume":"25","author":"Burger","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib276","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the \u03b1v integrin\/TGF-\u03b2 axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuron.2025.08.015_bib277","doi-asserted-by":"crossref","first-page":"CT062","DOI":"10.1158\/1538-7445.AM2023-CT062","article-title":"Abstract CT062: GBM AGILE: A global, phase 2\/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma","volume":"83","author":"Mellinghoff","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib278","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1200\/JCO.23.00493","article-title":"Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization","volume":"41","author":"Rahman","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib279","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167725","article-title":"A brain-tumor neural circuit controls breast cancer progression in mice","volume":"133","author":"Xiong","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuron.2025.08.015_bib280","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/0008-5472.CAN-24-1779","article-title":"Neural Circuitries between the Brain and Peripheral Solid Tumors","volume":"84","author":"Chen","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib281","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamaoncol.2022.0864","article-title":"Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class","volume":"8","author":"Samuel","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.neuron.2025.08.015_bib282","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA Reductase Inhibitor Lovastatin Reverses the Learning and Attention Deficits in a Mouse Model of Neurofibromatosis Type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib283","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pediatrneurol.2011.06.016","article-title":"Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study","volume":"45","author":"Acosta","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuron.2025.08.015_bib284","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1073\/pnas.91.8.3191","article-title":"Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia","volume":"91","author":"Lyons","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.08.015_bib285","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sc.2015.172","article-title":"Effects of tacrolimus and erythropoietin in experimental spinal cord lesion in rats: functional and histological evaluation","volume":"54","author":"de Mesquita Coutinho","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neuron.2025.08.015_bib286","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-230526","article-title":"Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine","volume":"95","author":"Silva","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuron.2025.08.015_bib287","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/brb3.16","article-title":"Neuroprotective effects of Tacrolimus (FK-506) and Cyclosporin (CsA) in oxidative injury","volume":"1","author":"Yousuf","year":"2011","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuron.2025.08.015_bib288","first-page":"56","article-title":"Therapeutic strategies for peripheral nerve injuries: FK506 and electrostimulation","volume":"10","author":"Chi","year":"2023","journal-title":"Plast. Aesthet. Res."},{"key":"10.1016\/j.neuron.2025.08.015_bib289","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2024.11.003","article-title":"Calcineurin\/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer disease","volume":"146","author":"Sordo","year":"2025","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2025.08.015_bib290","article-title":"The effect of tacrolimus-containing polyethylene glycol-modified maghemite nanospheres on reducing oxidative stress and accelerating the healing spinal cord injury of rats based on increasing M2 macrophages","volume":"15","author":"Wang","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.neuron.2025.08.015_bib291","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/ijms25020847","article-title":"Nerve Wrap for Local Delivery of FK506\/Tacrolimus Accelerates Nerve Regeneration","volume":"25","author":"Xiao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib292","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.799151","article-title":"Tacrolimus-Induced Neurotrophic Differentiation of Adipose-Derived Stem Cells as Novel Therapeutic Method for Peripheral Nerve Injury","volume":"15","author":"Yao","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuron.2025.08.015_bib293","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13451","article-title":"Adult spinal cord tissue transplantation combined with local tacrolimus sustained-release collagen hydrogel promotes complete spinal cord injury repair","volume":"56","author":"Zhao","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.neuron.2025.08.015_bib294","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/ijc.25295","article-title":"Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents","volume":"127","author":"Goard","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neuron.2025.08.015_bib295","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061256","article-title":"Inflammation in the Peripheral Nervous System after Injury","volume":"12","author":"Gu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuron.2025.08.015_bib296","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cell.2020.10.016","article-title":"Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer","volume":"183","author":"Banh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib297","doi-asserted-by":"crossref","first-page":"E2008","DOI":"10.1073\/pnas.1402944111","article-title":"GFR\u03b11 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling","volume":"111","author":"He","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.08.015_bib298","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-0173(97)00061-1","article-title":"Salient features of synaptic organisation in the cerebral cortex","volume":"26","author":"Somogyi","year":"1998","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuron.2025.08.015_bib299","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuron.2017.03.003","article-title":"Diazepam Binding Inhibitor Promotes Stem Cell Expansion Controlling Environment-Dependent Neurogenesis","volume":"94","author":"Dumitru","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2025.08.015_bib300","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmet.2019.04.004","article-title":"Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation","volume":"30","author":"Duman","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuron.2025.08.015_bib301","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin Receptor \u03b12\u03b4-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2025.08.015_bib302","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcdb.2023.09.001","article-title":"New insights into the role of thrombospondin-1 in glioblastoma development","volume":"155","author":"Bikfalvi","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuron.2025.08.015_bib303","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/carcin\/bgn077","article-title":"A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer","volume":"29","author":"Wu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neuron.2025.08.015_bib304","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9440(10)65140-1","article-title":"Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas","volume":"155","author":"Streit","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuron.2025.08.015_bib305","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.cgt.7700266","article-title":"The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts","volume":"7","author":"Jin","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.neuron.2025.08.015_bib306","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1073\/pnas.171460498","article-title":"Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor","volume":"98","author":"Rodr\u00edguez-Manzaneque","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.08.015_bib307","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.08.015_bib308","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1749-6632.1999.tb11316.x","article-title":"The arrangement of glutamate receptors in excitatory synapses","volume":"868","author":"Takumi","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuron.2025.08.015_bib309","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0896-6273(00)81202-7","article-title":"Activity coregulates quantal AMPA and NMDA currents at neocortical synapses","volume":"26","author":"Watt","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2025.08.015_bib310","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1152\/jn.00070.2003","article-title":"The NMDA-to-AMPA Ratio at Synapses Onto Layer 2\/3 Pyramidal Neurons Is Conserved Across Prefrontal and Visual Cortices","volume":"90","author":"Myme","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuron.2025.08.015_bib311","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuron.2025.08.015_bib312","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ddstr.2006.11.012","article-title":"Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action","volume":"3","author":"Du","year":"2006","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.neuron.2025.08.015_bib313","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(94)90514-2","article-title":"Over-additive anticonvulsant effect of memantine and NBQX in kindled rats","volume":"259","author":"L\u00f6scher","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuron.2025.08.015_bib314","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1460-9568.1993.tb00224.x","article-title":"Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy","volume":"5","author":"L\u00f6scher","year":"1993","journal-title":"Eur. J. Neurosci."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662732500621X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662732500621X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:51:36Z","timestamp":1758988296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089662732500621X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":314,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S089662732500621X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2025.08.015","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel approaches to clinical trial design in cancer neuroscience","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2025.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}